IO Biotech Inc Financial Flexibility Index
IO Biotech Inc financial flexibility index. IO Biotech Inc (IOBT) has a Financial Flexibility Index of -0.47x as of September 2025. Free cash flow of $-18.47 Million (operating CF $-18.48 Million minus capex $4.00K) represents 0% of total liabilities ($39.05 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of IO Biotech Inc (2019–2024)
Financial flexibility index of IO Biotech Inc from 2019 to 2024. Historical Financial Flexibility Index trend for IO Biotech Inc across 6 annual periods. Explore IO Biotech Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
IO Biotech Inc Financial Flexibility Index by Year (2019–2024)
IO Biotech Inc financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for IO Biotech Inc. For the full cash flow conversion analysis, see IOBT cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.98x | $-82.30 Million | $-82.35 Million | $20.68 Million | ▲ +2.2% |
| 2023 | -4.07x | $-71.41 Million | $-71.74 Million | $17.56 Million | ▲ +10.8% |
| 2022 | -4.56x | $-59.04 Million | $-59.73 Million | $12.95 Million | ▼ -16.7% |
| 2021 | -3.91x | $-40.49 Million | $-40.65 Million | $10.36 Million | ▼ -21.6% |
| 2020 | -3.21x | $-9.80 Million | $-9.96 Million | $3.05 Million | ▼ -300.7% |
| 2019 | -0.80x | $-8.74 Million | $-8.89 Million | $10.89 Million | — |